# Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

> **NCT02299570** · PHASE2 · COMPLETED · sponsor: **Rebiotix Inc.** · enrollment: 150 (actual)

## Conditions studied

- Enterocolitis Clostridium Difficile Recurrent

## Interventions

- **BIOLOGICAL:** RBX2660 (microbiota suspension)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02299570
- **Lead sponsor:** Rebiotix Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-01
- **Final completion:** 2018-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02299570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02299570, "Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02299570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*